openPR Logo
Press release

What's driving the Antifungal Drugs Market Size ? Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer, Kramer Laboratories, Novartis International AG, Pfizer

06-19-2019 07:52 PM CET | Health & Medicine

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport
What's driving the Antifungal Drugs Market Size ? Merck & Co.,

MarketStudyReport.com adds New Report on Global Antifungal Drugs Market to its research database. The report focuses on global major leading players with information such as company profiles, Growth, product segment, technology segment, end user segment and region.

According to research report Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) , the antifungal drugs market is projected to display a robust growth represented by a CAGR of 3.70% during 2018 2023.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1550842/?utm_source=openpr.com&utm_medium=Razz

Company Analysis - Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer, Kramer Laboratories, Novartis International AG, Pfizer.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others). The report analyses the Antifungal Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023.

Over the recent years, Antifungal Drugs market has been witnessing growth on account of several driving factors including growing prevalence of fungal infections such as candidiasis and aspergillosis, increasing popularity of over-the-counter drugs, and increase in availability of innovative antifungals. Moreover, increasing awareness regarding fatal antifungal diseases, growing medical spending, favorable government initiatives, public private partnership have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in pharmaceuticals research, growing scope in developing countries with large population such as China and India is anticipated to impel the market growth of the antifungal drugs market. However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market performance during forecasted period.

In this research report, the market is segmented on the basis of drug class and therapeutic indications. By drug class, the azoles class antifungals are predicted to hold their dominant position in the market. By therapeutic indications, drugs use in the treatment of candidiasis are anticipated to creates their dominance in global antifungal drugs market. Amongst the regions, North America accounts for the largest regional share in the global antifungal drugs market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and highly advanced medical infrastructure.

The report titled Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) , has covered and analysed the potential of antifungal drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the antifungal drugs. Additionally, the report also highlights market entry strategies for various companies across the globe.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1550842/?utm_source=openpr.com&utm_medium=Razz

Global Antifungal Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antifungal Drugs Market Size, Growth, Forecast
Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications

Regional Antifungal Drugs Market North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antifungal Drugs Market Size, Growth, Forecast
Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications

Country Analysis U.S., Canada, Germany, U.K, France, China, Japan, India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antifungal Drugs Market Size, Growth, Forecast
Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications

Other Report Highlights
Market Dynamics Drivers and Restraints.
Market Trends.
Porter Five Forces Analysis.
SWOT Analysis.

The report could be customized according to the client s specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Antifungal Drugs Products Outlook
5. Global Antifungal Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. Global Antifungal Drugs Market: Segmental Analysis
6.1 Global Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
6.1.1 Global Antifungal Drugs Market Size, By Drug Class, 2017 (%)
6.1.2 Global Antifungal Drugs Market Size, By Drug Class, 2023 (%)
6.2 Global Azole Class Antifungal Drugs Market Size, By Value (2013-2023)
6.3 Global Echinocandins Class Antifungal Drugs Market Size, By Value (2013-2023)
6.4 Global Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
6.5 Global Other Antifungal Drugs Market Size, By Value (2013-2023)
6.6 Global Antifungal Drugs: Market Attractiveness, By Drug Class
6.7 Global Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
6.7.1 Global Aspergillus Antifungal Drugs Market Size, By Value (2013-2023)
6.7.2 Global Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
6.7.3 Global Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
6.6.2 Global Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
7. Global Antifungal Drugs Market: Regional Analysis
7.1 Global Antifungal Drugs Market Size, By Region : Breakdown (%)
7.1.1 Global Antifungal Drugs Market Size, By Region, 2017 (%)
7.1.2 Global Antifungal Drugs Market Size, By Region, 2023 (%)
8. North America Antifungal Drugs Market: An Analysis
8.1 North America Antifungal Drugs Market: Segment Analysis
8.2 North America Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
8.2.1 North America Antifungal Drugs Market Size, By Drug Class, 2017 (%)
8.2.2 North America Antifungal Drugs Market Size, By Drug Class, 2023 (%)
8.3 North America Azoles Antifungal Drugs Market Size, By Value (2013-2023)
8.4 North America Echinocandins Antifungal Drugs Market Size, By Value (2013-2023)
8.5 North America Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
8.6 North America Others Antifungal Drugs Market Size, By Value (2013-2023)
8.7 North America Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
8.7.1 North America Aspergillus Antifungal Drugs Size, By Value (2013-2023)
8.7.2 North America Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
8.7.3 North America Candidiasis Antifungal Drugs Size, By Value (2013-2023)
8.7.4 North America Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
8.8 North America Antifungal Drugs Market: Country Analysis (U.S and Canada)
8.8.1 U.S Antifungal Drugs Market, By Value (2013-2023)
8.8.2 U.S Antifungal Drugs Market, By Drug Class, By Value (2013-2023)

More Details on this ReporT; https://www.marketstudyreport.com/reports/global-antifungal-drugs-market-analysis-by-drug-class-azoles-echinocandins-polyenes-others-by-therapeutic-indications-candidiasis-aspergillosis-dermatophytosis-others-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-by-region-north-america-europe-asia-pacific-row-by-country-u-s-canada-germany-u-k-france-china-japan-india/?utm_source=openpr.com&utm_medium=Razz

Contact Us:

Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Antifungal Drugs Market Size ? Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer, Kramer Laboratories, Novartis International AG, Pfizer here

News-ID: 1781593 • Views:

More Releases from marketstudyreport.com

Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Power Technologies (Schneider Electric), Simplex, Shenzhen Sikes, Pite Tech
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders. Load Bank Market Size was estimated
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - John Deere, CNH Industrial, Kubota, AGCO, Claas, Yanmar, Mahindra, LOVOL
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc., Volkswagen AG, SAIC Motors, BYD Auto Co. Ltd., BMW Group, Nissan Motor Co. Ltd., Hyundai Group
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028. The operation is done to stop ligament tears and
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - Garrett Motion, Hanon Systems, UQM Technologies, FISCHER Fuel Cell Compressor
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug